C. J. Allen1, J. P. Meizoso1, J. J. Ray1, L. F. Teisch1, L. Zebib1, G. M. Moore1, N. Namias1, C. I. Schulman1, R. Dudaryk2, K. G. Proctor1 1University Of Miami,Trauma And Critical Care,Miami, FL, USA 2University Of Miami,Anaesthesiology,Miami, FL, USA
Introduction: Despite significant advances in trauma management, mortality from hemorrhagic shock remains the number one cause of death in trauma victims. Maintaining a PRBC:FFP:platelet ratio of 1:1:1 reduces mortality in trauma patients receiving a massive transfusion protocol (MTP). The ability to maintain this goal ratio in those requiring super massive transfusion protocol (S-MTP) of >30 units of PRBCs may be diminished due to logistical constraints and immediate supply limitations. We hypothesize that the timing and total administered blood component ratio is different between those who receive MTP versus S-MTP at a high volume level 1 trauma center.
Methods: Between January 2009 and January 2012, we prospectively observed all trauma patients requiring blood component transfusion, obtaining demographics, injury patterns, procedures, total fluid and transfusion requirements, and outcomes. Of those transfused, we retrospectively reviewed those with an MTP activation and obtained the quantity of each component (PRBC, FFP, platelets) administered at serial time increments in those patients. Comparisons were made between MTP (≤30 units PRBC) and S-MTP (>30 units PRBC) patients. Parametric data is represented as mean ± standard deviation, non-parametric as median (interquartile range). Student’s t-test, Mann-Whitney U, and Fisher’s Exact tests were used as appropriate.
Results: 268 total patients required a transfusion with 87 total MTP activations, 16 required S-MTP. Between MTP and S-MTP cohorts, ISS was 31±14 vs 42±18 (p=0.09), initial BE -6±11 vs -9±6 (p=0.173), ED SBP 92±41 vs 66±37 (p=0.03), 24h EBL 1.6(4.1)L vs 8.0(11.4)L (p<0.001), 24h PRBC of 16±7u vs 49±16u (p<0.001). Average ratio of PRBC:FFP:platelet at 24h was 1.6:1:2.0 in MTP, and 1.5:1:1.2 in S-MTP. The PRBC:FFP ratio for each patient was calculated at serial time increments, averaged and plotted in the figure. Within the first hour, S-MTP patients received 10.2±6.9u PRBC and 3.1±4.2u FFP; >7u difference. Overall mortality was 30% in the MTP group and 75% in the S-MTP group (p<0.001).
Conclusion: Likely due to logistical constraints and supply limitations, patients receiving S-MTP have lower than goal plasma transfusion immediately following MTP activation which may contribute to their increased mortality because they did not receive effective hemostatic resuscitation. Our results show the need for >10 units of plasma to be immediately available to this critically hemorrhaging population. Future investigation should focus on improvements of early S-MTP resuscitation by making more plasma readily available (ie liquid plasma) for immediate transfusion.